New biological markers of ventilator-associated pneumonia

Clinical Pulmonary Medicine

Volumn 14, Issue 2, 2007, Pages 93-98

  Ramirez, Paula ^a   Menendez, Rosario ^a   Torres, Antoni ^b  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

Author keywords

Biological markers; Diagnosis; Ventilator associated pneumonia

Indexed keywords

ANTIBIOTIC AGENT; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CYTOKINE; IMMUNOGLOBULIN; INTERLEUKIN 1; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; PROCALCITONIN; PROTEIN TREM 1; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANTIBIOTIC THERAPY; AREA UNDER THE CURVE; ARTIFICIAL VENTILATION; BACTERIAL PNEUMONIA; CLINICAL PRACTICE; CYTOKINE RELEASE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ECONOMIC EVALUATION; HEALTH CARE COST; HORMONE BLOOD LEVEL; HOSPITAL INFECTION; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; INFLAMMATION; LUNG LAVAGE; PROTEIN BLOOD LEVEL; REVIEW; SENSITIVITY AND SPECIFICITY; VENTILATOR ASSOCIATED PNEUMONIA;

EID: 34247628447     PISSN: 10680640     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.cpm.0000257584.73243.8d     Document Type: Review

References (48)

1. Niederman MS, Craven DE. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med. 2005;171:388-416.
2. Torres A, Carlet J. Ventilator-associated pneumonia. Eur Respir J.2001;17:1034-1045.
3. Fabregas N, Ewig S, Torres A, et al. Clinical diagnosis of ventilator-associated pneumonia revisited: comparative evaluation using immediate post mortem biopsies. Thorax. 1999;54:867-873.
4. El-Ebiary M, Soler N, Monton C, et al. Markers of ventilator-associated pneumonia. Clin Intensive Care. 1995;6:121-126.
5. Assicot M, Gendrel D, Carsin H, et al. High serum procalcitonin concentrations in patients with sepsis and infection. Lancet. 1993;341:515-518.
6. Dandona P, Nix D, Wilson MF, et al. Procalcitonin increase alter endotoxin injection in normal subjects. J Clin Endocrinol Metab. 1994;79:1605-1608.
7. Luzzani A, Polati E, Dorizzi R, et al. Comparison of procalcitonin and C-reactive protein as markers of sepsis. Crit Care Med. 2003;31:1737-1741.
8. Simon L, Gauvin F, Amre DK, et al. Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. CID. 2004;39:206-217.
9. Christ-Crain M, Jaccard-Stolz D, Bingisser R, et al. Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial. Lancet. 2004;363:600-607.
10. Hedlund J, Hansson LO. Procalcitonin and C-reactive protein levels community-acquired pneumonia: correlation with etiology and prognosis. Infection. 2000;28:68-73.
11. Brunkhorst FM, Al-Nawas B, Krummenauer F. Procalcitonin, C-reactive protein and APACHE II score for risk evaluation in patients with severe pneumonia. Clin Microbiol Infect. 2002;8:93-100.
12. Brunkhorst FM, Eberhard OK, Brunkhorst R. Discrimination of infectious and noninfectious causes of early acute respiratory distress syndrome by procalcitonin. Crit care Med. 1999;27:2172-2176.
13. Oppert M, Reinicke A, Müller C, et al. Elevations in procalcitonin but not C-reactive protein are associated with pneumonia after cardiopulmonary resuscitation. Resuscitation. 2002;53:167-170.
14. Duflo F, Debon R, Monneret G, et al. Alveolar and serum procalcitonin. Anesthesiology. 2002;96:74-79.
15. Gibot S, Cravoisy A, Levy B, et al. Soluble triggering receptor expressed on myeloid cells and the diagnosis of pneumonia. N Engl J Med. 2004;29:451-458.
16. Ramírez-Galleymore P, Garcia-Garcia MA, Tormo S. Procalcitonin as a marker of ventilator-associated pneumonia. Abstract for 19th Congress of the ESICM, Barcelona, Spain, 24-27 September, 2006.
17. Luyt CE, Guérin V, Combes A, et al. Procalcitonin kinetics as a prognostic marker of ventilator-associated pneumonia. Am J Respir Crit Care Med. 2005;171:48-53.
18. Pepys MB, Hirschfield GM. C-reactive protein: a critical update. J Clin Invest. 2003;111:1805-1812.
19. Cadwgan AM, Watson WA, Laing RB, et al. Presenting clinical features and C-reactive protein in the prediction of a positive stool culture in patients with diarrhoea. J Infect. 2000;41:159-161.
20. Gustafsson R, Johnson P, Algotsson L, et al. Vacuum-assisted closure therapy guided by C-reactive protein level in patients with deep sternal wound infection. J Thorac Cardiovasc Surg. 2002;123:895-900.
21. Hogevik H, Olaison L, Anderson R, et al. C-reactive protein is more sensitive than erythrocyte sedimentation rate for diagnosis of infective endocarditis. Infection. 1997;25:82-85.
22. Reny JL, Vuagnat A, Ract C, et al. Diagnosis and follow-up of infections in intensive care patients. Value of C-reactive protein compared with other clinical and biological variables. Crit Care Med. 2002;30:529-535.
23. Lobo SM, Lobo FR, Bota DP, et al. C-reactive protein levels correlate with mortality and organ failure in critically ill patients. Chest. 2003;123:2043-2049.
24. Povoa P, Coelho L, Almeida A. C-reactive protein as a marker of infection in critically ill patients. Clin Microbiol Infect. 2005;11:101-108.
25. Povoa P, Coelho E, Ameida A, et al. C-reactive protein as a marker of ventilator-associated pneumonia resolution: a pilot study. Eur Respir J. 2005;25:804-812.
26. Ioanas M, Ferrer M, Cavalcanti M, et al. Causes and predictors of non-response to treatment of the ICU-acquired pneumonia. Crit Care Med. 2004;32:938-945.
27. Bouchon A, Dietrich J, Colonna M. Inflammatory responses can be triggered by TREM-1, a novel receptor expressed on neutrophils and monocytes. J Immunol. 2000;164:4991-4995.
28. Bouchon A, Facchetti F, Weigad MA, et al. TREM-1 amplifies inflammation and is a crucial mediator of septic shock. Nature. 2001;410:1103-1107.
29. Gibot S, Kolopp-Sarda MN, Bollaert PE. Plasma level of a triggering receptor expressed on myeloid cells: its diagnosis accuracy in patients with suspected sepsis. Ann Intern Med. 2004;141:9-15.
30. Determann RG, Millo JL, Gibot S, et al. Serial changes in soluble triggering receptor expressed on myeloid cells in the lung during development of ventilator-associated pneumonia. Intensive Care Med. 2005;31:1495-1500.
31. Ein A, Abraham E. Can we make sense out of cytokines? Chest. 2000;117:932-934.
32. Thijs LG, Hack CE. Time course of cytokine levels in sepsis. Intensive Care Med. 1995;21:S258-S263.
33. Gattinoni L, Pelosi P, Suter PM, et al. Acute respiratory distress syndrome caused by pulmonary and extrapulmonary disease. Different syndromes? Am J Respir Crit Care Med. 1998;158:3-11.
34. Ware LB, Matthay MA. The acute respiratory distress syndrome. N Engl J Med. 2000;342:1334-1349.
35. Headley AS, Tolley E, Meduri GU. Infections and the inflammatory response in acute respiratory distress syndrome. Chest. 1997;111:1306-1321.
36. Meduri GU, Kohler G, Headley S, et al. Inflammatory cytokines in the BAL of patients with ARDS. Persistent elevation over time predict poor outcome. Chest. 1995;108:1303-1314.
37. Monton C, Torres A, El-Ebiary, et al. Cytokine expression in severe pneumonia: a bronchoalveolar lavage study. Crit Care Med. 1999;27:1745-1753.
38. Cavalcanti M, Ferrrer M, Ferrer R, et al. Risk and prognosis of ventilator-associated pneumonia in trauma patients. Crit Care Med. 2006;34:1067-1072.
39. Bonten MJM, Froon AHM, Gaillard CA, et al. The systemic inflammatory response in the development of ventilator-associated pneumonia. Am J Respir Crit Care Med. 1997;156:1105-1113.
40. Millo JL, Schultz MJ, Williams C, et al. Compartmentalisation of cytokines and cytokine inhibitors in ventilator-associated pneumonia. Intensive Care Med. 2004;30:68-74.
41. Bauer TT, Monton C, Torres A, et al. Comparison of systemic cytokine levels in patients with acute respiratory distress syndrome, severe pneumonia, and controls. Thorax. 2000;55:46-52.
42. Timsit JF, Cheval C, Gachot B, et al. Usefulness of a strategy based on bronchoscopy with direct examination of bronchoalveolar lavage fluid in the initial antibiotic therapy of suspected ventilator-associated pneumonia. Intensive Care Med. 2001;27:640-647.
43. Dupont H, Chalhoub V, Plantefève G. Variation of infected cell count in bronchoalveolar lavage and timing of ventilator-associated pneumonia. Intensive Care Med. 2004;30:1557-1563.
44. Cook D, Mandell L. Endotracheal aspiration in the diagnosis of ventilator-associated pneumonia. Chest. 2000;117:195-197.
45. Froon AHM, Bonten MJM, Gaillar CA, et al. Prediction of clinical severity and outcome of ventilator-associated pneumonia. Am J Respir Crit Care Med. 1998;158:1026-1031.
46. Duflo F, Debon R, Goudable J, et al. Alveolar and serum oxidative stress in ventilator-associated pneumonia. Br J Anaesth. 2002;89:231-236.
47. Lannergard A, Larsson A, Kragsbjerg P, et al. Correlations between serum amyloid protein and C-reactive protein in infectious diseases. Scand J Clin Lab Invest. 2003;63:267-272.
48. Yip TT, Chan JW, Cho WC, et al. Protein chip array profiling analysis in patients with severe acute respiratory syndrome identified serum amyloid protein as a biomarker potentially useful in monitoring the extent of pneumonia. Clin Chem. 2005;51:47-55.